Search WST
WEST PHARMACEUTICAL SERVICES INC
NYSE · CIK 105770
Last close364.98
Daily change-0.03 (-0.01%)
10 Years gain+399.44%
Dividends TTM0.88 (+4.76%)
Dividend yield0.24%
Fundamental Analysis
WST · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
50.8Momentum
62.0Acceleration
61.8Confidence
91.0Annual Revenue18
Quarterly Revenue55
Annual CFO18
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth10.6 / 25
Quality6.4 / 25
Capital Efficiency7.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics9.3 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 2.6428 percentage points.
Operating leverageOperating margin improved by 2.4039 percentage points.
ROIC expansionROIC improved by 2.307 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 2.3288%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Key Metrics
Revenue Growth TTM15.69%OK
Revenue CAGR 3Y2.12%OK
Gross Margin36.3%OK
Operating Margin20.6%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC19.1%OK
Incremental Operating Margin 3Y-36.33%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-2.33%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $3.07B | $1.10B | $584.90M | $754.80M | $468.90M | 35.91% | 19.03% | 15.25% | 18.71% | 72.7M |
| 2025 FY Dec 31, 2024 | $2.89B | $998.50M | $569.90M | $653.40M | $276.40M | 34.51% | 19.7% | 9.55% | 20.08% | 73.7M |
| 2025 FY Dec 31, 2023 | $2.95B | $1.13B | $676.00M | $776.50M | $414.50M | 38.28% | 22.92% | 14.05% | 26.34% | 75.3M |
| 2024 FY Dec 31, 2022 | $2.89B | $1.14B | $734.00M | $724.00M | $439.40M | 39.36% | 25.43% | 15.22% | 31.9% | 75.8M |
| 2023 FY Dec 31, 2021 | $2.83B | $1.18B | $752.30M | $584.00M | $330.60M | 41.52% | 26.57% | 11.68% | 35.8% | 76.3M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $3.29B | sum latest 4 fiscal quarters Revenue | OK | 0000105770-26-000099, 0000105770-25-000093 |
| Revenue Growth TTM | 15.69% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0000105770-26-000099, 0000105770-25-000093 |
| Revenue CAGR 3Y | 2.12% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0000105770-26-000010 |
| Revenue CAGR 5Y | 7.44% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0000105770-26-000010 |
| Gross Profit CAGR 3Y | -0.95% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0000105770-26-000010 |
| Operating Income Growth | 30.97% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0000105770-26-000099, 0000105770-25-000093 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 36.3% | Gross Profit / Revenue | OK | 0000105770-26-000099, 0000105770-25-000093 |
| Operating Margin | 20.6% | Operating Income / Revenue | OK | 0000105770-26-000099, 0000105770-25-000093 |
| ROIC | 19.1% | NOPAT / Average Invested Capital | OK | 0000105770-26-000099, 0000105770-25-000093 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0000105770-26-000099 |
| Current Ratio | 2.82x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 2.15x | (Cash + Short-term Investments) / Total Debt | OK | 0000105770-26-000099 |
| Revenue per Diluted Share | $46.12 | Revenue / Diluted Shares | OK | 0000105770-26-000099, 0000105770-25-000093 |